Effect of vitamin E and ticlopidine on platelet aggregation in Fabry's disease

Publisher Website
Google Scholar
Abstract
Thromboembolism, increased platelet aggregation and high plasma concentration of .beta.-thromboglobulin were observed frequently in hemizygotes and heterozygotes of Fabry''s disease. The administration of vitamin E and ticlopidine could improve the increased platelet aggregation in this disease. The platelet activation, probably induced by vascular endothelial damages, would accelerate atherosclerotic and thromboembolic vascular changes. Antiplatelet therapy will be effective for the prevention of these vascular complications in this disease.